<DOC>
	<DOCNO>NCT02707822</DOCNO>
	<brief_summary>The purpose study identify factor may influence tacrolimus ( TAC ) pharmacokinetics , impact gene polymorphism ( ABCB1 , CYP3A4 , CYP3A5 , POR ) pharmacokinetics TAC Taiwanese .</brief_summary>
	<brief_title>The Influence ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism Other Factors Tacrolimus Blood Concentration</brief_title>
	<detailed_description>TAC one important immunosuppressive agent organ transplantation . In patient dose concentration TAC difficult adjust narrow therapeutic index variable pharmacokinetics . Many factor affect pharmacokinetics TAC . Literature suggest ABCB1 , CYP3A4 , CYP3A5 , POR gene polymorphism may affect pharmacokinetics TAC . In addition , distribution TAC affect hematocrit albumin concentration . The pharmacokinetics TAC may also affect total protein , total bilirubin , creatinine , AST , ALT , gender , age , drug interaction , . This study intend analyze influence various factor , include drug , pharmacokinetics TAC .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>kidney transplant liver transplant 20 65 year old receive tacrolimus immunosuppressive drug Human immunodeficiency viruspositive status Retransplantation multiorgan transplantation nonAsian</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>gene polymorphism</keyword>
	<keyword>clinical factor</keyword>
</DOC>